Skip to main content
Clinical Trials/NCT02804490
NCT02804490CompletedPhase 3

Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status

Johns Hopkins Bloomberg School of Public Health1 site in 1 country255 target enrollmentStarted: March 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
255
Locations
1
Primary Endpoint
Infant vitamin A stores

Study Overview

Brief Summary

The purpose of this randomized control trial is to test the impact of provitamin A carotenoid biofortified maize meal consumption on maternal and infant vitamin A status.

Detailed Description

Vitamin A deficiency remains a major public health problem in low and middle income countries. Approximately 50% of Zambian children are thought to be affected. This randomized control trial will test the efficacy of provitamin A carotenoid biofortified maize meal consumption as a strategy to improve vitamin A status among lactating Zambian mothers and their infants. The investigators will enroll up to 255 mother/infant pairs to a three-month study, during which they will receive one of the following three interventions: 1) conventional white maize, 2) provitamin A carotenoid biofortified orange maize, or 3) preformed vitamin A fortified white maize.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Singleton birth
  • •No birth defects
  • •Free from chronic health conditions
  • •Infant received 100,000 IU vitamin A at 6 months of age
  • •Currently breastfeeding
  • •Not pregnant at 9 months post partum
  • •Hemoglobin > 8.0 g/dL for women and > 7.0 g/dL for infants

Exclusion Criteria

  • •Multiple birth
  • •Birth defects
  • •Any chronic health condition requiring regular medical visits
  • •Infant did not receive vitamin A capsule at 6 months of age
  • •No longer breastfeeding
  • •Hemoglobin ≤ 8.0 g/dL for women or ≤ 7.0 g/dL for infants

Arms & Interventions

White maize

Placebo Comparator

Conventional maize flour

Intervention: Conventional white maize (Dietary Supplement)

Biofortified maize

Experimental

Provitamin A carotenoid biofortified maize flour

Intervention: Provitamin A carotenoid biofortified maize (Dietary Supplement)

Fortified maize

Active Comparator

Retinyl palmitate fortified maize flour

Intervention: Preformed vitamin A fortified maize (Dietary Supplement)

Outcomes

Primary Outcomes

Infant vitamin A stores

Time Frame: 90 days

Total body vitamin A stores of infants measured by retinol isotope dilution

Secondary Outcomes

  • Maternal breast milk retinol(90 days)
  • Maternal plasma retinol(90 days)
  • Maternal dark adaptation(90 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials